Merck & Co has been fighting to defend its blockbuster type 2 diabetes therapy Januvia from generic competition for years, and a new judgment looks set to protect its third biggest-selling drug ...

This is attributed to declining sales of its blockbuster HPV vaccine – Gardasil – and an increased competition for some of its drugs, including Januvia. As an aside, new gaming products can be ...